Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.54
-0.60-3.96%
At close: -
$14.54
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
ACADIA Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:ACAD | Benzinga
ACADIA Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for ACADIA Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Needham
Morgan Stanley
Cantor Fitzgerald
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for ACADIA Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/28/2025 | Buy Now | — | UBS | Ashwani Verma44% | $25 → $22 | Maintains | Buy | Get Alert |
| 04/08/2025 | Buy Now | — | Needham | Ami Fadia56% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2025 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $20 → $20 | Assumes | → Equal-Weight | Get Alert |
| 02/27/2025 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 02/27/2025 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2025 | Buy Now | — | Needham | Ami Fadia56% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 02/11/2025 | Buy Now | — | Deutsche Bank | Neena Bitritto-Garg58% | → $22 | Initiates | → Hold | Get Alert |
| 01/03/2025 | Buy Now | — | Guggenheim | Yatin Suneja52% | $20 → $20 | Downgrade | Buy → Neutral | Get Alert |
| 11/07/2024 | Buy Now | — | Needham | Ami Fadia56% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 10/10/2024 | Buy Now | — | Raymond James | Danielle Brill43% | — | Reinstates | → Market Perform | Get Alert |
| 08/08/2024 | Buy Now | — | Citigroup | David Hoang35% | $30 → $23 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | — | UBS | Ashwani Verma44% | $25 → $23 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | — | Needham | Ami Fadia56% | $30 → $28 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $37 → $28 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | — | RBC Capital | Gregory Renza50% | $29 → $26 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $28 → $20 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/12/2024 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $30 → $28 | Maintains | Overweight | Get Alert |
| 06/27/2024 | Buy Now | — | BMO Capital | Keith Tapper31% | → $31 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | Buy Now | — | RBC Capital | Gregory Renza50% | $29 → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | Buy Now | — | B of A Securities | Tazeen Ahmad54% | $26 → $22 | Maintains | Neutral | Get Alert |
| 05/09/2024 | Buy Now | — | Needham | Ami Fadia56% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | $33 → $27 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | — | Citigroup | David Hoang35% | $30.19 → $30 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | — | Stifel | Paul Matteis43% | $26 → $21 | Maintains | Hold | Get Alert |
| 05/09/2024 | Buy Now | — | Mizuho | Uy Ear63% | $25 → $21 | Maintains | Neutral | Get Alert |
| 05/09/2024 | Buy Now | — | Baird | Joel Beatty67% | $31 → $28 | Maintains | Outperform | Get Alert |
| 05/06/2024 | Buy Now | — | Oppenheimer | Jay Olson61% | $19 → $19 | Maintains | Perform | Get Alert |
| 04/30/2024 | Buy Now | — | UBS | Ashwani Verma44% | $33 → $27 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 04/09/2024 | Buy Now | — | Needham | Ami Fadia56% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2024 | Buy Now | — | JP Morgan | Tessa Romero59% | $29 → $25 | Maintains | Overweight | Get Alert |
| 03/13/2024 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $40 → $30 | Maintains | Overweight | Get Alert |
| 03/12/2024 | Buy Now | — | Citigroup | David Hoang35% | $38 → $30.19 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | — | RBC Capital | Gregory Renza50% | $35 → $30 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | — | Mizuho | Uy Ear63% | $39 → $25 | Downgrade | Buy → Neutral | Get Alert |
| 03/12/2024 | Buy Now | — | JMP Securities | Jason Butler52% | $44 → $39 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $42 → $37 | Maintains | Overweight | Get Alert |
| 03/12/2024 | Buy Now | — | Baird | Joel Beatty67% | $40 → $31 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | — | Oppenheimer | Jay Olson61% | $25 → $19 | Maintains | Perform | Get Alert |
| 03/12/2024 | Buy Now | — | B of A Securities | Tazeen Ahmad54% | $33 → $30 | Maintains | Neutral | Get Alert |
| 03/12/2024 | Buy Now | — | Canaccord Genuity | Sumant Kulkarni42% | $40 → $33 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | → $33 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2024 | Buy Now | — | Needham | Ami Fadia56% | $36 → $32 | Maintains | Buy | Get Alert |
| 03/01/2024 | Buy Now | — | JP Morgan | Tessa Romero59% | $32 → $29 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | $33 → $33 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 02/28/2024 | Buy Now | — | RBC Capital | Gregory Renza50% | $36 → $35 | Maintains | Outperform | Get Alert |
| 02/28/2024 | Buy Now | — | Mizuho | Uy Ear63% | $40 → $39 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | — | Needham | Ami Fadia56% | $37 → $36 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | — | JMP Securities | Jason Butler52% | $42 → $42 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/05/2024 | Buy Now | — | Oppenheimer | Jay Olson61% | → $25 | Reiterates | Perform → Perform | Get Alert |
| 02/02/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 01/30/2024 | Buy Now | — | Baird | Joel Beatty67% | → $40 | Initiates | → Outperform | Get Alert |
| 01/24/2024 | Buy Now | — | Needham | Joseph Stringer52% | → $37 | Upgrade | Hold → Buy | Get Alert |
| 12/29/2023 | Buy Now | — | Mizuho | Uy Ear63% | $35 → $40 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $31 → $40 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/18/2023 | Buy Now | — | Stifel | Paul Matteis43% | $25 → $27 | Maintains | Hold | Get Alert |
| 12/14/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 12/14/2023 | Buy Now | — | Deutsche Bank | Neena Bitritto-Garg58% | → $25 | Downgrade | Buy → Hold | Get Alert |
| 12/13/2023 | Buy Now | — | Citigroup | David Hoang35% | → $38 | Initiates | → Buy | Get Alert |
| 12/12/2023 | Buy Now | — | Deutsche Bank | Neena Bitritto-Garg58% | → $25 | Initiates | → Buy | Get Alert |
| 11/06/2023 | Buy Now | — | Canaccord Genuity | Sumant Kulkarni42% | $38 → $40 | Maintains | Buy | Get Alert |
| 11/06/2023 | Buy Now | — | Mizuho | Uy Ear63% | $20 → $35 | Upgrade | Neutral → Buy | Get Alert |
| 11/03/2023 | Buy Now | — | JMP Securities | Jason Butler52% | $39 → $42 | Maintains | Market Outperform | Get Alert |
| 11/03/2023 | Buy Now | — | RBC Capital | Gregory Renza50% | $32 → $33 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $30 → $31 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | — | UBS | Ashwani Verma44% | → $33 | Initiates | → Buy | Get Alert |
| 10/10/2023 | Buy Now | — | JP Morgan | Tessa Romero59% | $29 → $32 | Upgrade | Neutral → Overweight | Get Alert |
| 08/22/2023 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 08/07/2023 | Buy Now | — | JP Morgan | Tessa Romero59% | $28 → $29 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | — | Canaccord Genuity | Sumant Kulkarni42% | $39 → $38 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $30 → $30 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | — | Oppenheimer | Jay Olson61% | → $25 | Reiterates | Perform → Perform | Get Alert |
| 08/03/2023 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | → $33 | Reiterates | Buy → Buy | Get Alert |
| 07/28/2023 | Buy Now | — | Oppenheimer | Jay Olson61% | $23 → $25 | Maintains | Perform | Get Alert |
| 07/17/2023 | Buy Now | — | Canaccord Genuity | Sumant Kulkarni42% | $28 → $39 | Maintains | Buy | Get Alert |
| 07/17/2023 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $36 → $42 | Maintains | Overweight | Get Alert |
| 07/14/2023 | Buy Now | — | RBC Capital | Gregory Renza50% | $28 → $33 | Maintains | Outperform | Get Alert |
| 07/14/2023 | Buy Now | — | Citigroup | Neena Bitritto-Garg58% | $21.6 → $27 | Maintains | Neutral | Get Alert |
| 07/14/2023 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $21 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/14/2023 | Buy Now | — | JMP Securities | Jason Butler52% | $31 → $39 | Maintains | Market Outperform | Get Alert |
| 07/14/2023 | Buy Now | — | Oppenheimer | Jay Olson61% | $20 → $23 | Maintains | Perform | Get Alert |
| 07/14/2023 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | $28 → $33 | Maintains | Buy | Get Alert |
| 07/11/2023 | Buy Now | — | Morgan Stanley | Jeffrey Hung51% | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 06/14/2023 | Buy Now | — | JMP Securities | Jason Butler52% | $23 → $31 | Maintains | Market Outperform | Get Alert |
| 06/14/2023 | Buy Now | — | Mizuho | Uy Ear63% | → $20 | Reiterates | Neutral → Neutral | Get Alert |
| 06/14/2023 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2023 | Buy Now | — | B of A Securities | Tazeen Ahmad54% | $23 → $26 | Maintains | Neutral | Get Alert |
| 05/09/2023 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | → $33 | Reiterates | → Overweight | Get Alert |
| 05/09/2023 | Buy Now | — | RBC Capital | Gregory Renza50% | → $27 | Reiterates | → Outperform | Get Alert |
| 05/09/2023 | Buy Now | — | JMP Securities | Jason Butler52% | $22 → $23 | Maintains | Outperform | Get Alert |
| 05/09/2023 | Buy Now | — | HC Wainwright & Co. | Andrew Fein58% | → $28 | Reiterates | → Buy | Get Alert |
| 05/09/2023 | Buy Now | — | Citigroup | Neena Bitritto-Garg58% | $21 → $21.6 | Maintains | Neutral | Get Alert |
| 04/14/2023 | Buy Now | — | Mizuho | Uy Ear63% | → $20 | Reiterates | → Neutral | Get Alert |
| 03/20/2023 | Buy Now | — | JP Morgan | Tessa Romero59% | $19 → $21 | Maintains | Neutral | Get Alert |
| 03/14/2023 | Buy Now | — | B of A Securities | Tazeen Ahmad54% | → $23 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for ACADIA Pharmaceuticals (ACAD) stock?
The latest price target for ACADIA Pharmaceuticals (NASDAQ:ACAD) was reported by UBS on April 28, 2025. The analyst firm set a price target for $22.00 expecting ACAD to rise to within 12 months (a possible 51.31% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ACADIA Pharmaceuticals (ACAD)?
The latest analyst rating for ACADIA Pharmaceuticals (NASDAQ:ACAD) was provided by UBS, and ACADIA Pharmaceuticals maintained their buy rating.
When was the last upgrade for ACADIA Pharmaceuticals (ACAD)?
The last upgrade for ACADIA Pharmaceuticals Inc happened on January 24, 2024 when Needham raised their price target to $37. Needham previously had a hold for ACADIA Pharmaceuticals Inc.
When was the last downgrade for ACADIA Pharmaceuticals (ACAD)?
The last downgrade for ACADIA Pharmaceuticals Inc happened on January 3, 2025 when Guggenheim changed their price target from $20 to $20 for ACADIA Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for ACADIA Pharmaceuticals (ACAD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ACADIA Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ACADIA Pharmaceuticals was filed on April 28, 2025 so you should expect the next rating to be made available sometime around April 28, 2026.
Is the Analyst Rating ACADIA Pharmaceuticals (ACAD) correct?
While ratings are subjective and will change, the latest ACADIA Pharmaceuticals (ACAD) rating was a maintained with a price target of $25.00 to $22.00. The current price ACADIA Pharmaceuticals (ACAD) is trading at is $14.54, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
